Clinical Trial Update: A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 study comparing eplerenone with losartan for mild-to-moderate hypertension has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Losartan (losartan)
• eplerenone (eplerenone)

Snippet

Sponsor: Pfizer | Conditions: Hypertension | Phase 2 | Status: TERMINATED